Colorectal carcinoma in the course of inflammatory bowel diseases
Deletion mutations in an Australian series of HNPCC patients
Dupuytren's disease and the risk of malignant neoplasms
Expanding the genetic basis of copy number variation in familial breast cancer
Frequency of the common MYH mutations (G382D and Y165C) in MMR mutation positive and negative HNPCC patients
Gene expression profiling of Xeroderma pigmentosum
Genetic variants in MUTYH are not associated with endometrial cancer risk
Hereditary cancer in clinical practice transfers to BioMed Central (editorial)
Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families
- Dębniak, Tadeusz, Gromowski, Tomasz, Cybulski, Cezary, Serrano-Fernandez, Pablo, Lubiński, Jan, Scott, Rodney J., Gronwald, Jacek, Huzarski, Tomasz, Byrski, Tomasz, Kurzawski, Grzegorz, Dymerska, Dagmara, Górski, Bohdan, Paszkowska-Szczur, Katarzyna
MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer
The importance of a large sample cohort for studies on modifier genes influencing disease severity in FAP patients
- Talseth-Palmer, Bente A., Wijnen, Juul T., Van Wezel, Tom, Vasen, Hans F. A., Scott, Rodney J., Andreassen, Eva K., Barker, Daniel, Jagmohan-Changur, Shantie, Tops, Carli M., Meldrum, Cliff, The Dutch Cancer Genetics Group, Spigelman, Allan, Hes, Frederik J.
The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation
When is a mutation not a mutation: the case of the c.594-2A>C splice variant in a woman harbouring another BRCA1 mutation in trans
Are you sure you would like to clear your session, including search history and login status?